|
Canada-0-SILVERSMITHS ไดเรกทอรีที่ บริษัท
|
ข่าว บริษัท :
- Two Polio Vaccines - World Health Organization (WHO)
Poliomyelitis (polio) is a highly infectious viral disease that largely affects children under 5 years of age The virus is transmitted by person-to-person spread mainly through the faecal-oral route or, less frequently, by a common vehicle (e g contaminated water or food) and multiplies in the intestine, from where it can invade the nervous system and cause paralysis
- Immunization, Vaccines and Biologicals
Polio can be prevented through immunization Polio vaccine, given multiple times, almost always protects a child for life The development of effective vaccines to prevent paralytic polio was one of the major medical breakthroughs of the 20th century There are six different vaccines to stop polio transmission: Inactivated polio vaccine (IPV) – protects against poliovirus types 1, 2, and 3
- WHO prequalifies an additional novel oral polio vaccine, strengthening . . .
The World Health Organization (WHO) has prequalified an additional novel oral polio vaccine type 2 (nOPV2), further strengthening the global supply of a vaccine at the heart of efforts to stop poliovirus type 2 outbreaks more sustainably and accelerate progress towards polio eradication
- Safety profile of nOPV2 vaccine
The first polio vaccine was developed by Jonas Salk, from formaldehyde-inactivated wild polio viruses Salk’s IPV was tested and proved highly efficacious against paralytic poliomyelitis in a large clinical trial conducted in US schoolchildren in 1954, which was rapidly followed by licensure of the product and implementation of mass
- Poliomyelitis - World Health Organization (WHO)
WHO fact sheet on poliomyelitis, a highly infectious disease caused by a virus The fact sheet includes key facts, global caseload, Global Eradication Initiative, progress, WHO response
- Poliomyelitis - World Health Organization (WHO)
Inactivated polio vaccine (IPV) was developed in 1955 by Dr Jonas Salk Also called the Salk vaccine IPV consists of inactivated (killed) poliovirus strains of all three poliovirus types IPV is given by intramuscular or intradermal injection and needs to be administered by a trained health worker
- Poliomyelitis - World Health Organization (WHO)
Polio Vaccine Standardization Written Standards The WHO Guidelines for the safe production and quality control of inactivated poliomyelitis vaccine manufactured from wild polioviruses were developed in 2003 and revised in 2018
- Polio
Immunization, Vaccines and Biologicals The Immunization, Vaccines and Biologicals department is responsible for targeting vaccine-preventable diseases, guiding immunization research and establishing immunization policy
- Humanitarian access improves quality of polio vaccination campaign in . . .
A five-day mass polio vaccination campaign in the Gaza Strip concluded on Wednesday, reaching nearly 603 000 children under 10 years of age with novel oral polio vaccine type 2 (nOPV2) following comprehensive, simultaneous access to all five governorates during the ongoing ceasefire The campaign was conducted as part of emergency efforts to end an ongoing poliovirus outbreak and prevent
- Mass polio vaccination campaign to continue in the Gaza Strip
The second round of the polio vaccination campaign in the Gaza Strip was completed yesterday, with an overall 556 774 children under the age of 10 being vaccinated with a second dose of polio vaccine, and 448 425 children between 2- to 10-years-old receiving vitamin A, following the three phases conducted in the last weeks
|
|